Rubina Qamar

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline

Nadine Tung, Judy C. Boughey, Lori J. Pierce et al. · Journal of Clinical Oncology · 2020 · 324 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil et al. · Journal of Clinical Oncology · 2013 · 235 citations

Pharmacy, Oncology, Pharmacotherapy +17

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant, Rubina Qamar, Stephen Richey et al. · The Lancet Oncology · 2023 · 200 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Fertility Preservation in People With Cancer: ASCO Guideline Update

H. Irene Su, Christina Lacchetti, Joseph M. Letourneau et al. · Journal of Clinical Oncology · 2025 · 181 citations

Veterinary Medicine, Oncology, Assisted Reproductive Technologies +16